This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Endourology
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • AMA Interim 2023
      • SUO 2023
      • ESMO 2023
      • IBCN 2023
      • ASTRO 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer

Conferences

Recent Abstracts
#AUA14 - Targeted magnetic resonance imaging/ultrasound fusion biopsy is a significantly better predictor of total prostate cancer tumor volume than random 12-core biopsy - Session Highlights May 20, 2014
#AUA14 - Bilateral multifocal papillary type I renal cell carcinoma: Clinical characteristics and association with chronic renal insufficiency - Session Highlights May 20, 2014
#AUA14 - Utilization of sacrocolpopexy: Comparison of practice patterns between urologists and gynecologists using a national database - Session Highlights May 20, 2014
#AUA14 - Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial - Session Highlights May 20, 2014
#AUA14 - Early experience of radium-223 treatment for metastatic castrate resistant prostate cancer: A preliminary report - Session Highlights May 20, 2014
#AUA14 - Treatment practice patterns in metastatic castration-resistant prostate cancer patients prior to receiving sipuleucel-T: Data from PROCEED - Session Highlights May 20, 2014
#AUA14 - State-of-the-Art Lecture: Evidence-based vs consensus-based guidelines on PSA: What are the differences and why? One vs the other? - Session Highlights May 20, 2014
#AUA14 - State-of-the-Art Lecture: Use of positron emission tomography in advanced prostate cancer - Session Highlights May 20, 2014
#AUA14 - State-of-the-Art Lecture: Development of bladder cancer biomarkers - Session Highlights May 20, 2014
#AUA14 - Mortality benefit of screening men with a family history of prostate cancer as a surrogate for high genetic risk in the PLCO Trial - Session Highlights May 20, 2014
#AUA14 - Analysis of renal mass biopsy prior to extirpative surgery and validation of the Michigan Risk Stratification algorithm - Session Highlights May 20, 2014
#AUA14 - Prostate cancer outcomes after primary therapy in renal transplant patients - Session Highlights May 20, 2014
#AUA14 - Can hematuria be used to predict RCC vs oncocytoma histology? - Session Highlights May 20, 2014
#AUA14 - Session Highlights: Experience with active surveillance (AS) in patients with renal mass ≥ 4cm: Assessment of growth kinetics and outcomes May 20, 2014
#AUA14 - Patients with anatomically “simple” renal masses are more likely to be placed on active surveillance than those with anatomically “complex” lesions - Session Highlights May 20, 2014
#AUA14 - Session Highlights: Tumor anatomic complexity predicts growth kinetics of renal masses under active surveillance May 20, 2014
#AUA14 - Performance of multiparametric MRI for high grade prostate cancer: Correlation with whole-mount pathology - Session Highlights May 20, 2014
#AUA14 - Multiparametric MRI for detection of radio-recurrent prostate cancer: What constitutes an optimal dataset? - Session Highlights May 20, 2014
#AUA14 - External beam radiation therapy versus high-intensity focused ultrasound for localized prostate cancer: A matched pair comparison - Session Highlights May 20, 2014
#AUA14 - Magnetic resonance imaging/ultrasound fusion-guided biopsy for re-targeting of atypical small acinar proliferation - Session Highlights May 20, 2014
Page 478 of 537
  • Start
  • Prev
  • 473
  • 474
  • 475
  • 476
  • 477
  • 478
  • 479
  • 480
  • 481
  • 482
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free